期刊文献+

丹参预防人工全髋关节置换术后下肢深静脉血栓形成的研究 被引量:24

Salvia miltiorrhiza Bge for prevention of deep vein thrombosis after total hip replacement
下载PDF
导出
摘要 目的:对比观察采用丹参注射液预防人工全髋关节置换(THR)术后下肢深静脉血栓形成(DVT)的临床效果。方法:将1998年1月至2004年8月行人工全髋关节置换术的患者随机分为未用药组和用药组,其中未用药组56例,未预防性使用任何药物;用药组60例,围手术期给予丹参注射液预防性治疗。术后第7、14天,两组患者均行患肢彩色多谱勒超声检查,了解DVT形成情况及两组术后DVT的发生率。结果:未用药组中有23例DVT阳性,DVT的发生率41.1%,用药组中有11例DVT阳性,DVT的发生率18.3%,两组比较,差异有统计学意义(P<0.05)。未用药组近端DVT的发生率为14.3%,用药组近端DVT的发生率为1.7%,两组比较,差异有统计学意义(P<0.05)。用药组未发现术中术后出血增多以及药物不良反应。结论:丹参可显著降低人工全髋关节置换术后下肢深静脉血栓的发生,且具有良好的安全性。 Objective:To evaluate the efficacy and safety of Salvia miltiorrhiza Bge in preventing deep--vein thrombosis (DVT) after total hip replacement. Methods:From January 1998 to August 2004, we performed total hip replacement for 56 control patients and for 60 patients who had been given Salvia miltiorrhiza Bge injection for prevening deep--vein thrombosis. All the patients received Color Doppler ultrasonography examination 7 and 14 days after operation. Results: DVT occurred in 18. 3 % of the Salvia miltiorrhiza Bge patients and the reduction was significant(P〈0.05 ) compared to the control group. The incidence of proximal DVT was also reduced significantly(P〈0.05) from 14.3% of the control group to 1.7% of the Saliva miltiorrhiza Bge group. Conclusions:Salvia miltiorrhiza Bge can significantly reduce the incidence of deep--vein thrombosis after total hip replacement.
出处 《中国中医骨伤科杂志》 CAS 2006年第3期14-17,共4页 Chinese Journal of Traditional Medical Traumatology & Orthopedics
关键词 关节成形术 置换 深静脉血栓 丹参 术后 Arthroplasty Replacement Hip Deep vein thrombosis Salvia miltiorrhiza Bge
  • 相关文献

参考文献18

  • 1吕厚山,徐斌.人工关节置换术后下肢深静脉血栓形成[J].中华骨科杂志,1999,19(3):155-156. 被引量:955
  • 2杨刚,吕厚山,高健,寇伯龙,袁燕林,徐斌.低分子肝素预防人工髋、膝关节置换术后下肢深静脉血栓形成的研究[J].中华外科杂志,2000,38(1):25-27. 被引量:392
  • 3王友华,刘璠,王洪,吴菊,侍德.维生素E、FDP预防全髋关节置换术后深静脉血栓形成的研究[J].中华创伤骨科杂志,2005,7(6):512-514. 被引量:28
  • 4Lensing AW, Buller HR, Prandoni P, et al. Contrast venography, the gold standard for the diagnosis deep-vein thrombosis:improvement in observer agreement. Thromb Haemost, 1992,67:8-12
  • 5Stulberg BN, Insall JN, Williams GW, et al. Deep-vein thrombosis following total knee replacement: an analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg (Am), 1984,66: 194-201
  • 6Hull RD, Raskob GE. Prophylaxis of venous thromboembolic disease following hip and knee surgery. J Bone Joint Sury (Am),1986, 68:146-150
  • 7Lieberman JR, Greets WH. Prevention of venous thromboembolism after total hip and knee arthroplasty. J Bone Joint Sury(Am), 1994, 76:1239-1250
  • 8Hoek JA, Nurmohamed MT, Hamelynck, et al. Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid. Thromb Haemost , 1992, 67:28-32
  • 9Hull R, Raskob G, Pineo G, et al. A comparison of subcutaneous lowmolecular- weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med, 1993, 329:1370-1376
  • 10Turpie AG, Levine MN, Hirsh J, et al. A randomized controlled trial of a low- molecular weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgey. N Engl J Med, 1986, 315:925-929

二级参考文献34

  • 1栗剑,王福权,徐阳.骨折术后深静脉血栓的防治[J].中华创伤骨科杂志,2004,6(8):938-939. 被引量:36
  • 2沈施仁,钱镜秋.维生素C,维生素E对麻醉手术中红细胞内过氧化脂质...[J].中华麻醉学杂志,1993,13(3):170-171. 被引量:2
  • 3张经国,药理实验方法学,1982年
  • 4计岚仙,中国医学科学院学报,1981年,3卷,增刊,41页
  • 5杨保津,丹参.生物学及其应用,1990年
  • 6江文德,血阏证与活血化阏研究,1990年
  • 7徐理纳,血阏证与活血化阏研究,1990年
  • 8徐叔云,药理实验方法学,1990年
  • 9徐理纳,动物学研究,1987年,8卷,增刊,39页
  • 10徐理纳,血小板.基础与临床,1987年

共引文献1619

同被引文献362

引证文献24

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部